<?xml version='1.0' encoding='UTF-8'?>
<FreeMedForms_PIMs>
  <PIMSources>
    <Source id="beers2003" name="Beers criteria 2003 updated" pmid="14662625" country="us"/>
    <Source id="laroche2007" pmid="" country="fr"/>
    <Source id="priscus2010" pmid="" country="de"/>
  </PIMSources>
  <PIMTypes>
    <Type id="PimOld" fr="PRESCRIPTION POTENTIELLEMENT INAPPROPRIÉE CHEZ LE SUJET ÂGÉ: INDÉPENDANTE DES DIAGNOSTICS OU DES CONDITIONS PATHOLOGIQUES" en="POTENTIALLY INAPPROPRIATE MEDICATION USE IN OLD ADULTS: INDEPENDANT TO DIAGNOSES OR CONDITIONS" de="POTENTIELL Innapropriate Medikamenten in alte Erwachsene: INDEPENDENT Diagnosen ODER BEDINGUNGEN" es="Medicación potencialmente inapropiado USO EN ADULTOS DE EDAD: INDEPENDIENTE DE DIAGNÓSTICOS Y CONDICIONES"/>
    <Type id="PimOldDepDiag" fr="PRESCRIPTION POTENTIELLEMENT INAPPROPRIÉE CHEZ LE SUJET ÂGÉ: DÉPENDANTE DES DIAGNOSTICS OU DES CONDITIONS PATHOLOGIQUES" en="POTENTIALLY INAPPROPRIATE MEDICATION USE IN OLD ADULTS: DEPENDANT TO DIAGNOSIS OR CONDITIONS" de="POTENTIELL Innapropriate Medikamenten in alte Erwachsene: Abhängig zur Diagnose oder BEDINGUNGEN" es="Medicación potencialmente inapropiado USO EN ADULTOS DE EDAD: DEPENDIENTES DE DIAGNÓSTICO Y CONDICIONES"/>
  </PIMTypes>

<PIMs>
  <PIM_Source id="beers2003" name="Beers, 2003">
  <PIM_Type id="PimOld" name="POTENTIALLY INNAPROPRIATE MEDICATION USE IN OLD ADULTS: INDEPENDANT TO DIAGNOSES OR CONDITIONS" >
  <PIM level="low">
    <Molecules>
      <Molecule name="propoxyphene" />
    </Molecules>
    <Risk lang="en" value="Offers few analgesic advantages over acetaminophen, yet has the adverse effects of other narcotic drugs."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="INDOMETACIN" />
    </Molecules>
    <Risk lang="en" value="Of all available nonsteroidal anti-inflammatory drugs, this drug produces the most CNS adverse effects."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="pentazocine" />
    </Molecules>
    <Risk lang="en" value="Narcotic analgesic that causes more CNS adverse effects, including confusion and hallucinations, more commonly than other narcotic drugs. Additionally, it is a mixed agonist and antagonist."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Trimethobenzamide" />
    </Molecules>
    <Risk lang="en" value="One of the least effective antiemetic drugs, yet it can cause extrapyramidal adverse effects."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule class="Muscle relaxants and antispasmodics" />
    </Molecules>
    <Risk lang="en" value="Most muscle relaxants and antispasmodic drugs are poorly tolerated by elderly patients, since these cause anticholinergic adverse effects, sedation, and weakness. Additionally, their effectiveness at doses tolerated by elderly patients is questionable."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Flurazepam" />
    </Molecules>
    <Risk lang="en" value="This benzodiazepine hypnotic has an extremely long half-life in elderly patients (often days), producing prolonged sedation and increasing the incidence of falls and fracture. Medium- or short-acting benzodiazepines are preferable"/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Amitriptyline" />
      <Molecule name="chlordiazepoxide-amitriptyline" />
      <Molecule name="perphenazine-amitriptyline" />
    </Molecules>
    <Risk lang="en" value="Because of its strong anticholinergic and sedation properties, amitriptyline is rarely the antidepressant of choice for elderly patients."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Doxepin" />
    </Molecules>
    <Risk lang="en" value="Because of its strong anticholinergic and sedating properties, doxepin is rarely the antidepressant of choice for elderly patients."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Meprobamate" />
    </Molecules>
    <Risk lang="en" value="This is a highly addictive and sedating anxiolytic. Those using meprobamate for prolonged periods may become addicted and may need to be withdrawn slowly."/>
  </PIM>



  <PIM level="high">
    <Molecules>
      <Molecule name="lorazepam" maxDailyDose="3" maxDailyDoseUnit="mg"/>
      <Molecule name="oxazepam" maxDailyDose="60" maxDailyDoseUnit="mg" />
      <Molecule name="alprazolam" maxDailyDose="2" maxDailyDoseUnit="mg" />
      <Molecule name="temazepam" maxDailyDose="15" maxDailyDoseUnit="mg" />
      <Molecule name="triazolam" maxDailyDose="0.25" maxDailyDoseUnit="mg" />
    </Molecules>
    <Risk lang="en" value="Because of increased sensitivity to benzoadiazepines in elderly patients, smaller doses may be effective as well as safer. Total daily doses should rarely exceed the suggested maximums."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule class="LONG ACTING BENZODIAZEPINES" />
    </Molecules>
    <Risk lang="en" value="These drugs have a long half-life in elderly patients (often several days), producing prolonged sedation and increasing the risk of falls and fractures. Short- and intermediate-acting benzodiazepines are preferred if a benzodiazepine is required."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Disopyramide" />
    </Molecules>
    <Risk lang="en" value="Of all antiarrhythmic drugs, this is the most potent negative inotrope and therefore may induce heart failure in elderly patients. It is also strongly anticholinergic. Other antiarrhythmic drugs should be used."/>
  </PIM>
  <PIM level="low">
    <Molecules>
      <Molecule name="Digoxin" />
    </Molecules>
    <Risk lang="en" value="Decreased renal clearance may lead to increased risk of toxic effects."/>
  </PIM>
  <PIM level="low">
    <Molecules>
      <Molecule name="dipyridamole" shortActing="true" />
    </Molecules>
    <Risk lang="en" value="May cause orthostatic hypotension."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Methyldopa" />
      <Molecule name="methyldopa-hydrochlorothiazide" />
    </Molecules>
    <Risk lang="en" value="May cause bradycardia and exacerbate depression in elderly patients."/>
  </PIM>
  <PIM level="low">
    <Molecules>
      <Molecule name="Reserpine" maxDailyDose="0.25" maxDailyDoseUnit="mg" />
    </Molecules>
    <Risk lang="en" value="May induce depression, impotence, sedation, and orthostatic hypotension."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Chlorpropamide" />
    </Molecules>
    <Risk lang="en" value="It has a prolonged half-life in elderly patients and could cause prolonged hypoglycemia. Additionally, it is the only oral hypoglycemic agent that causes SIADH."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule class="GASTROINTESTINAL ANTISPASMODIC DRUGS" />
    </Molecules>
    <Risk lang="en" value="GI antispasmodic drugs are highly anticholinergic and have uncertain effectiveness. These drugs should be avoided (especially for long-term use)."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule class="Anticholinergics and antihistamines" />
    </Molecules>
    <Risk lang="en" value="All nonprescription and many prescription antihistamines may have potent anticholinergic properties. Nonanticholinergic antihistamines are preferred in elderly patients when treating allergic reactions."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Diphenhydramine" />
    </Molecules>
    <Risk lang="en" value="May cause confusion and sedation. Should not be used as a hypnotic, and when used to treat emergency allergic reactions, it should be used in the smallest possible dose."/>
  </PIM>
  <PIM level="low">
    <Molecules>
      <Molecule name="Ergot mesyloids (Hydergine)" />
      <Molecule name="cyclandelate" />
    </Molecules>
    <Risk lang="en" value="Have not been shown to be effective in the doses studied."/>
  </PIM>
  <PIM level="low">
    <Molecules>
      <Molecule name="Ferrous sulfate" maxDailyDose="325" maxDailyDoseUnit="mg"/>
    </Molecules>
    <Risk lang="en" value="Doses 􏰂325 mg/d do not dramatically increase the amount absorbed but greatly increase the incidence of constipation."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule class="barbiturates" />
    </Molecules>
    <Risk lang="en" value="Are highly addictive and cause more adverse effects than most sedative or hypnotic drugs in elderly patients."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Meperidine" />
    </Molecules>
    <Risk lang="en" value="Not an effective oral analgesic in doses commonly used. May cause confusion and has many disadvantages to other narcotic drugs."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Ticlopidine" />
    </Molecules>
    <Risk lang="en" value="Has been shown to be no better than aspirin in preventing clotting and may be considerably more toxic. Safer, more effective alternatives exist."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Ketorolac" />
    </Molecules>
    <Risk lang="en" value="Immediate and long-term use should be avoided in older persons, since a significant number have asymptomatic GI pathologic conditions."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule class="Amphetamines and anorexic agents" />
    </Molecules>
    <Risk lang="en" value="These drugs have potential for causing dependence, hypertension, angina, and myocardial infarction."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule class="LONG HALF-LIFE NON-COX-SELECTIVE NSAIDS" />
    </Molecules>
    <Risk lang="en" value="Have the potential to produce GI bleeding, renal failure, high blood pressure, and heart failure."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="fluoxetine" />
    </Molecules>
    <Risk lang="en" value="Long half-life of drug and risk of producing excessive CNS stimulation, sleep disturbances, and increasing agitation. Safer alternatives exist."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule class="stimulant laxatives" />
    </Molecules>
    <Risk lang="en" value="In long-term use, may exacerbate bowel dysfunction."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Amiodarone" />
    </Molecules>
    <Risk lang="en" value="Associated with QT interval problems and risk of provoking torsades de pointes. Lack of efficacy in older adults."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Orphenadrine" />
    </Molecules>
    <Risk lang="en" value="Causes more sedation and anticholinergic adverse effects than safer alternatives."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Guanethidine" />
    </Molecules>
    <Risk lang="en" value="May cause orthostatic hypotension. Safer alternatives exist."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Guanadrel" />
    </Molecules>
    <Risk lang="en" value="May cause orthostatic hypotension."/>
  </PIM>
  <PIM level="low">
    <Molecules>
      <Molecule name="Cyclandelate" />
    </Molecules>
    <Risk lang="en" value="Lack of efficacy."/>
  </PIM>
  <PIM level="low">
    <Molecules>
      <Molecule name="ISOXSUPRINE" />
    </Molecules>
    <Risk lang="en" value="Lack of efficacy."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Nitrofurantoin" />
    </Molecules>
    <Risk lang="en" value="Potential for renal impairment. Safer alternatives available."/>
  </PIM>
  <PIM level="low">
    <Molecules>
      <Molecule name="Doxazosin" />
    </Molecules>
    <Risk lang="en" value="Potential for hypotension, dry mouth, and urinary problems."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Methyltestosterone" />
    </Molecules>
    <Risk lang="en" value="Potential for prostatic hypertrophy and cardiac problems."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Thioridazine" />
    </Molecules>
    <Risk lang="en" value="Greater potential for CNS and extrapyramidal adverse effects."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Mesoridazine" />
    </Molecules>
    <Risk lang="en" value="CNS and extrapyramidal adverse effects."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="nifedipine" shortActing="true"/>
    </Molecules>
    <Risk lang="en" value="Potential for hypotension and constipation."/>
  </PIM>
  <PIM level="low">
    <Molecules>
      <Molecule name="Clonidine" />
    </Molecules>
    <Risk lang="en" value="Potential for orthostatic hypotension and CNS adverse effects."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Mineral oil" />
    </Molecules>
    <Risk lang="en" value="Potential for aspiration and adverse effects. Safer alternatives available."/>
  </PIM>
  <PIM level="low">
    <Molecules>
      <Molecule name="Cimetidine" />
    </Molecules>
    <Risk lang="en" value="CNS adverse effects including confusion."/>
  </PIM>
  <PIM level="low">
    <Molecules>
      <Molecule name="Ethacrynic acid" />
    </Molecules>
    <Risk lang="en" value="Potential for hypertension and fluid imbalances. Safer alternatives available."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Desiccated thyroid" />
    </Molecules>
    <Risk lang="en" value="Concerns about cardiac effects. Safer alternatives available."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule class="Amphetamines" />
    </Molecules>
    <Risk lang="en" value="CNS stimulant adverse effects."/>
  </PIM>
  <PIM level="low">
    <Molecules>
      <Molecule name="Estrogens only" route="oral"/>
    </Molecules>
    <Risk lang="en" value="Evidence of the carcinogenic (breast and endometrial cancer) potential of these agents and lack of cardioprotective effect in older women."/>
  </PIM>
  </PIM_Type>



  <PIM_Type id="PimOldDepDiag" name="POTENTIALLY INNAPROPRIATE MEDICATION USE IN OLD ADULTS: DEPENDANT TO DIAGNOSES OR CONDITIONS">
  <PIM level="high">
    <Molecules>
      <Molecule name="Disopyramide" />
      <Molecule name="high sodium content drugs" />
    </Molecules>
    <Diseases>
      <Disease icd="heartFailure" />
    </Diseases>
    <Risk lang="en" value="Negative inotropic effect. Potential to promote fluid retention and exacerbation of heart failure."/>
  </PIM>

  <PIM level="high">
    <Molecules>
      <Molecule name="Phenylpropanolamine" />
      <Molecule name="pseudoephedrine" />
      <Molecule name="diet pills" />
      <Molecule name="amphetamines" />
    </Molecules>
    <Diseases>
      <Disease icd="Hypertension" />
    </Diseases>
    <Risk lang="en" value="May produce elevation of blood pressure secondary to sympathomimetic activity."/>
  </PIM>

  <PIM level="high">
    <Molecules>
      <Molecule name="NON-STEROIDAL ANTI-INFLAMMATORIES" />
      <Molecule name="ACIDE ACETYLSALICYLIQUE" maxDailyDose="325" maxDailyDoseUnit="mg" />
    </Molecules>
    <Diseases>
      <Disease icd="GastroDuodenalUlcers" />
    </Diseases>
    <Risk lang="en" value="May exacerbate existing ulcers or produce new/additional ulcers. (coxibs exluded)"/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Clozapine" />
      <Molecule name="chlorpromazine" />
      <Molecule name="thioridazine" />
      <Molecule name="thiothixene" />
    </Molecules>
    <Diseases>
      <Disease icd="SeizureEpilepsy" />
    </Diseases>
    <Risk lang="en" value="May lower seizure thresholds."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Aspirin" />
      <Molecule name="NON-STEROIDAL ANTI-INFLAMMATORIES" />
      <Molecule name="dipyridamole" />
      <Molecule name="ticlopidine" />
      <Molecule name="clopidogrel" />
    </Molecules>
    <Diseases>
      <Disease icd="BloodClottingDisorders" />
      <Disease icd="AnticoagulantTherapy" />
    </Diseases>
    <Risk lang="en" value="May prolong clotting time and elevate INR values or inhibit platelet aggregation, resulting in an increased potential for bleeding."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="ANTICHOLINERGICS AND ANTIHISTAMINES" />
      <Molecule name="GASTROINTESTINAL ANTISPASMODIC DRUGS" />
      <Molecule name="oxybutynin" />
      <Molecule name="flavoxate" />
      <Molecule name="ANTIDEPRESSANTS" />
      <Molecule name="decongestants" />
      <Molecule name="tolterodine" />
    </Molecules>
    <Diseases>
      <Disease icd="BladderOutflowObstruction" />
    </Diseases>
    <Risk lang="en" value="May decrease urinary flow, leading to urinary retention."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="􏰨alpha-Blockers"/>
      <Molecule name="ANTICHOLINERGICS AND ANTIHISTAMINES"/>
      <Molecule name="tricyclic antidepressants"/>
      <Molecule name="long acting benzodiazepines" />
    </Molecules>
    <Diseases>
      <Disease icd="StressIncontinence" />
    </Diseases>
    <Risk lang="en" value="May produce polyuria and worsening of incontinence."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Tricyclic antidepressants" />
    </Molecules>
    <Diseases>
      <Disease icd="Arrhythmias" />
    </Diseases>
    <Risk lang="en" value="Concern due to proarrhythmic effects and ability to produce QT interval changes."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Metoclopramide" />
      <Molecule name="conventional antipsychotics" />
      <Molecule name="tacrine" />
    </Molecules>
    <Diseases>
      <Disease icd="Parkinson" />
    </Diseases>
    <Risk lang="en" value="Concern due to their antidopaminergic/cholinergic effects."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Decongestants"/>
      <Molecule name="theophylline"/>
      <Molecule name="methylphenidate"/>
      <Molecule name="IMAO NON SELECTIFS"/>
      <Molecule name="IMAO-A SELECTIFS"/>
      <Molecule name="IMAO-B SELECTIFS"/>
      <Molecule name="amphetamines" />
    </Molecules>
    <Diseases>
      <Disease icd="Insomnia" />
    </Diseases>
    <Risk lang="en" value="Concern due to CNS stimulant effects."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Barbiturates"/>
      <Molecule name="ANTICHOLINERGICS AND ANTIHISTAMINES"/>
      <Molecule name="MUSCLE RELAXANTS AND ANTISPASMODICS"/>
      <Molecule name="dextroAmphetamine"/>
      <Molecule name="methylphenidate"/>
      <Molecule name="methamphetamine"/>
      <Molecule name="pemolin" />
    </Molecules>
    <Diseases>
      <Disease icd="CognitiveImpairment" />
    </Diseases>
    <Risk lang="en" value="Concern due to CNS-altering effects."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="BENZODIAZEPINES AND RELATED"/>
      <Molecule name="methyldopa"/>
      <Molecule name="reserpine"/>
      <Molecule name="guanethidine" />
    </Molecules>
    <Diseases>
      <Disease icd="Depression" />
    </Diseases>
    <Risk lang="en" value="May produce or exacerbate depression. PS: Long-term benzodiazepine prescription."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="dextroAmphetamine"/>
      <Molecule name="methylphenidate"/>
      <Molecule name="methamphetamine"/>
      <Molecule name="pemolin"/>
      <Molecule name="fluoxetine" />
    </Molecules>
    <Diseases>
      <Disease icd="Anorexia" />
      <Disease icd="Malnutrition" />
    </Diseases>
    <Risk lang="en" value="Concern due to appetite-suppressing effects."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="SHORT ACTING BENZODIAZEPINES"/>
      <Molecule name="INTERMEDIATE ACTING BENZODIAZEPINES"/>
      <Molecule name="TRICYCLIC ANTIDEPRESSANTS"/>
    </Molecules>
    <Diseases>
      <Disease icd="Syncope" />
      <Disease icd="Falls" />
    </Diseases>
    <Risk lang="en" value="May produce ataxia, impaired psychomotor function, syncope, and additional falls."/>
  </PIM>
  <PIM level="low">
    <Molecules>
      <Molecule name="SELECTIVE SEROTONIN REUPTAKE INHIBITORS"/>
    </Molecules>
    <Diseases>
      <Disease icd="SIADH" />
      <Disease icd="Hyponatremia" />
    </Diseases>
    <Risk lang="en" value="May exacerbate or cause SIADH."/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="Bupropion" />
    </Molecules>
    <Diseases>
      <Disease icd="SeizureDisorder" />
    </Diseases>
    <Risk lang="en" value="May lower seizure threshold."/>
  </PIM>
  <PIM level="low">
    <Molecules>
      <Molecule name="Olanzapine" />
    </Molecules>
    <Diseases>
      <Disease icd="Obesity" />
    </Diseases>
    <Risk lang="en" value="May stimulate appetite and increase weight gain"/>
  </PIM>
  <PIM level="high">
    <Molecules>
      <Molecule name="LONG ACTING BENZODIAZEPINES"/>
      <Molecule name="propranolol" />
    </Molecules>
    <Diseases>
      <Disease icd="COPD" />
    </Diseases>
    <Risk lang="en" value="CNS adverse effects. May induce respiratory depression. May exacerbate or cause respiratory depression."/>
  </PIM>
  <PIM level="low">
    <Molecules>
      <Molecule name="CALCIUM CHANNEL ANTAGONISTS"/>
      <Molecule name="ANTICHOLINERGICS AND ANTIHISTAMINES"/>
      <Molecule name="TRICYCLIC ANTIDEPRESSANTS" />
    </Molecules>
    <Diseases>
      <Disease icd="ChronicConstipation" />
    </Diseases>
    <Risk lang="en" value="May exacerbate constipation."/>
  </PIM>
  </PIM_Type>
  </PIM_Source>

</PIMs>
</FreeMedForms_PIMs>
